| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cingulate Inc. (CING) has 11 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. CING is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 199.5K | $981.5K | - | |
| CFO | 64.5K | $317.3K | - | |
| VP | 52.5K | $258.3K | - | |
| COO | 31.0K | $152.5K | - | |
| Other | 30.0K | $147.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2021 | Schaffer Shane J. | Chief Executive Officer | Buy | 16,500 | $0.00 | - | New | -67.7% | -73.6% |